nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

15.06.2017 | Correspondence

Diagnostic Dilemmas in Aggressive Large B Cell Neoplasms with Enigmatic Immunohistochemical Profile: How Far Should We Investigate?

verfasst von: Neha Singh, Sunil Pasricha, Narendra Agrawal, Jatin S. Gandhi, Ajit Panaych, Anurag Mehta, Rayaz Ahmed, Dinesh Bhurani

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Sai JW (2013) Aggressive B-cell lymphomas: how many categories do we need? Mod Pathol 26(1):S42–S56

Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM et al (2010) Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica 95:1342–1349CrossRefPubMedPubMedCentral

Narita T, Inagaki A, Kobayashi T et al (2015) t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs. Blood Cancer J 5(2):285CrossRef

An G, Xu Y, Shi L et al (2013) t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome. Leuk Res 37(10):1251–1257CrossRefPubMed

Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951CrossRefPubMed

Avet-Loiseau H, Malard F, Campion L et al (2011) Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor? Blood 117(6):2009–2011CrossRefPubMed

Tinguely M, Thies S, Frigerio S et al (2014) IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1). Leuk Lymphoma 55(1):136–142CrossRefPubMed

Salaverria I, Akasaka T, Gesk S et al (2012) The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype. Genes Chromosomes Cancer 51(4):338–343CrossRefPubMed

Song Y, Cao Z, Li L et al (2010) Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation. Chin J Cancer 29:781–786CrossRefPubMed

Titel: Diagnostic Dilemmas in Aggressive Large B Cell Neoplasms with Enigmatic Immunohistochemical Profile: How Far Should We Investigate?
verfasst von: Neha Singh
Sunil Pasricha
Narendra Agrawal
Jatin S. Gandhi
Ajit Panaych
Anurag Mehta
Rayaz Ahmed
Dinesh Bhurani
Publikationsdatum: 15.06.2017
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2018
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-017-0839-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Diagnostic Dilemmas in Aggressive Large B Cell Neoplasms with Enigmatic Immunohistochemical Profile: How Far Should We Investigate?

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Diagnosis of Compound Heterozygous Hb Tak/β-Thalassemia and HbD-Punjab/β-Thalassemia by HbA2 Levels on Capillary Electrophoresis

Evaluating New Markers for Minimal Residual Disease Analysis by Flow Cytometry in Precursor B Lymphoblastic Leukemia

Hemophagocytic Lymphohistiocytosis: A Confusing Problem of the Diagnosis of Visceral Leishmaniasis

Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact

A Compound Heterozygous Asian Indian Inversion Deletion Gγ(Aγδβ)0 with β-Thalassemia in Central India: A Case Report

Clinical Features and Outcomes of 666 Cases with Therapy-Related Myelodysplastic Syndrome (t-MDS)

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie